HOME >> BIOLOGY >> NEWS
Unique interplay between tumor and blood vessel cells promotes angiogenesis and tumor growth

Scientists now have a more complete understanding of how cancer cells send signals to surrounding tissues to promote development of the blood supply needed to support tumor growth. For the first time, it has been shown that signals expressed by tumor cells can directly interact with the outer membrane of adjacent blood vessel cells and influence growth and development. The research, published in the July issue of Cancer Cell, may provide a new and more efficient target for antiangiogenic therapy.

Tumor cells, like other cells, require blood vessels to deliver oxygen and nutrients and to remove waste. Scientists have known for some time that tumor cells can stimulate blood vessel growth by secreting growth factors that promote angiogenesis. However, most human cancer therapies based on targeting these factors have been less than successful. Dr. Cun-Yu Wang from the University of Michigan and colleagues designed a series of studies to search for other signals that play a critical role in tumor angiogenesis.

The researchers examined factors that were upregulated when cancer cells were stimulated with a known growth factor. They found that angiogenic factors stimulated the mitogen-activated protein kinase (MAPK) pathway to induce the Notch ligand Jagged1 in head and neck squamous cell carcinoma cells. Jagged1 triggered Notch activation in neighboring blood vessel cells and promoted formation of new vessels. Notch signaling is known to be critical for specification of cell fate during development, and there is evidence that Notch plays a role in blood vessel formation. Angiogenesis and tumor growth was significantly enhanced in Jagged1-expressing cancer cells and high levels of Jagged1 were correlated with tumor size and blood vessel content.

Although Notch activation alone in tumor cells was not sufficient to induce angiogenesis, elevated levels of Jagged initiated crosstalk between tumor cells and blood vessel cells and stimulated tumor growth a
'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2879
Cell Press
18-Jul-2005


Page: 1 2

Related biology news :

1. Unique tomatoes tops in disease-fighting antioxidants
2. Unique estrogen receptor linked to metastatic breast cancer
3. Unique imaging uncovers the invisible world where surfaces meet
4. Unique gene regulation gives chilly bugs survival advantage at bottom of the world
5. Unique Huntingtons study moves forward
6. Unique dual target specificity of kinase inhibitor key for success against cancer
7. Unique soybean lines hold promise for producing allergy-free soybeans
8. Uniquely human component of language found in gregarious birds
9. Unique equine cataract surgery offered on routine basis
10. Unique genetic profile helps over-45s conceive naturally
11. Unique library of plant genes germinates, takes root at UNC

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based ... entered into license agreements with Housey Pharma’s HMI subsidiary to gain access to ... have annual Research and Development spending in excess of US $10 billion. , ...
(Date:8/7/2020)... ... 06, 2020 , ... Nine middle school teachers from eight ... a unique professional development program that provides advanced STEM (science, technology, engineering and ... nationwide. , Created in partnership between the National Stem Cell Foundation and The ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien ... announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical ... development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... The Indoor ... launch of Safe Space™ for businesses of all types to ensure cleanliness, distancing and ... , A Safe Space™ enabled business will provide a health performance index ...
Breaking Biology Technology:
Cached News: